Table: begin end state 1 53 cytoplasmic 54 75 transmembrane 76 114 non-cytoplasmic 115 139 transmembrane 140 171 cytoplasmic 172 199 transmembrane 200 210 non-cytoplasmic 211 232 transmembrane 233 239 cytoplasmic 240 260 transmembrane 261 279 non-cytoplasmic 280 298 transmembrane 299 322 cytoplasmic 323 345 transmembrane 346 372 non-cytoplasmic 373 397 transmembrane 398 418 cytoplasmic 419 439 transmembrane 440 445 non-cytoplasmic 446 470 transmembrane 471 476 cytoplasmic 477 493 transmembrane 494 499 non-cytoplasmic 500 520 transmembrane 521 542 cytoplasmic
Input: >PP_4946 MGFVGKCTGRCNLQKKNGCTFFALLHSIRRLGATTNGVVAHDKNKRQGTRMGNPLTITFV IYIAAMVLIGFAAYRATNNLSDYILGGRSLGSVVTALSAGASDMSGWLLMGLPGAIYFAG LSEAWIAIGLTVGAYLNWLFVAGRLRVQTEHNGDALTLPDYFSSRFEDNSGLLRIISAIV ILVFFTIYCASGIVAGARLFESTFGMSYETALWAGAAATIAYTFVGGFLAVSWTDTVQAS LMIFALILTPVIVLISTGGFDQTFAAIEAVNPANFDMLKGATFIGIISLMGWGLGYFGQP HILARFMAADSVKSIAKARRISMTWMILCLAGTCAVGFFGIAYFSAHPELAGPVSENHER VFIELAKILFNPWVAGVLLSAILAAVMSTLSCQLLVCSSALTEDFYKAFLRKNASQVELV WVGRLMVLAVALIAIAMAANPENRVLGLVAYAWAGFGAAFGPVVLISVLWKGMTRNGALA GIVVGALTVILWKNFDTLGLYEIIPGFLFASIAIVLVSKLGSPSQTMVKRFEAADAAYHA DK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server